DENGUE FEVER Flashcards
This acute febrile phase usually lasts 2−7 days and is often accompanied by facial flushing, skin erythema, generalized body ache, myalgia, arthralgia, retro-orbital eye pain, photophobia, rubeliform exanthema and headache (1).
Dengue fever
Dermatological manifestation in DF
rubeliform exanthema
when the temperature drops to 37.5−38°C or less and remains below this level, usually on days 3–8 Day of illness.
time of defervescence
The period of clinically significant plasma leakage usually last
24−48 hours.
may be the earliest sign of plasma leakage.
A rapid and progressive decrease in platelet count to about 100 000 cells/mm3
and a rising haematocrit above the baseline that is usually preceded by leukopenia (≤ 5000 cells/mm3) (4).
As the patient survives the 24−48 hour critical phase, a gradual reabsorption of extravascular compartment fluid takes place in the following
48−72 hours
Recovery phase
A case of severe dengue is defined as a suspected dengue patient with one or more of the following
i) severe plasma leakage that leads to shock (dengue shock) and/or fluid accumulation with respiratory distress;
(ii) severe bleeding;
(iii) severe organ impairment.
is a form of hypovolaemic shock and results from continued vascular permeability and plasma leakage.
Dengue shock syndrome (DSS)
Severe organ involvement in dengue fever
- Liver: AST or ALT>=1000 • CNS: Impaired consciousness
* Heart and other organs
incubation period of
4–10 days
is the best marker of a recent dengue infection.
Specific IgM
True or false
Primary infections are characterized by high levels of IgM and low levels of IgG, while low levels of IgM with high levels of IgG characterize secondary infections
True
is the method of choice for determination of specific serotype
Neutralization Test
Discharge criteria:
-> all of the following criteria must be present
o No fever for 48 hours o Increasing trend of platelet count o Stable haematocrit without intravenous fluids o Improvement in clinical picture o No respiratory distress
intravenous fluid therapy
0.9% saline or
Ringer Lactate at maintenance rate